🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 5 (from laksa000)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa005.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.cdc.gov/covid/php/surveillance/index.html\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.cdc.gov/covid/php/surveillance/index.html\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html","crawl_time":1775464001,"first_indexed_time":1722533829,"http_code":200,"src_unparsed":"gov,cdc!www,\/covid\/php\/surveillance\/index.html s443","src_root_hash":"17308952984333333205","history_drop_reason":null,"meta_title":"Surveillance and Data Analytics | Covid | CDC","meta_descriptions":["COVID-19 surveillance and data analytics"],"attrs_boilerpipe_text":"This page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page.\nCOVID-19 Surveillance Data in the United States\nEarly Indicators\nTest positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the  impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity.\n% Test Positivity\n2.1%\nWeek ending 2026-03-28\nPrevious Week 2.3%\n% ED visits diagnosed as COVID-19\n0.3%\nWeek ending 2026-03-28\nPrevious Week 0.3%\nSeverity Indicators\nHospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19.\nHospitalization rate per 100,000 population\n0.4\nWeek ending 2026-03-28\nPrevious week 0.9\n% of All Deaths in U.S. Due to COVID-19\n0.3%\nWeek ending 2026-03-28\nPrevious Week 0.3%\nCOVID-19 Death Rates\nAdditional COVID-19 Data and Visualizations\nCOVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S.\nSurvey results at the national and state level monitoring COVID-19 vaccination uptake and confidence\nNCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more\nCDC shares wastewater data for infectious diseases to help make informed public health decisions.\nThe Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN.\nNREVSS is a laboratory-based system that monitors respiratory and enteric virus activity.\nCDC uses genomic surveillance to identify and track SARS-CoV-2 variants.\nMar. 19, 2026","attrs_markdown":"[Skip directly to site content](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#content) [Skip directly to search](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#cdc-search__input) [Skip directly to On This Page](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#first-on-this-page)\n\n![](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/uswds\/us_flag_small.png) An official website of the United States government\n\n[Here's how you know](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#gov-notice)\n\n![](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/uswds\/icon-dot-gov.svg)\n\n**Official websites use .gov**\n\nA **.gov** website belongs to an official government organization in the United States.\n\n![](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/uswds\/icon-https.svg)\n\n**Secure .gov websites use HTTPS**\n\nA **lock** (  ) or **https:\/\/** means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n\n[![Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/logo\/logo-notext.svg)](https:\/\/www.cdc.gov\/)\n\n[Covid](https:\/\/www.cdc.gov\/covid\/index.html)\n\nExplore This Topic\n\n[For Everyone](https:\/\/www.cdc.gov\/covid\/index.html)\n\n- [About COVID-19](https:\/\/www.cdc.gov\/covid\/about\/index.html)\n- [Symptoms](https:\/\/www.cdc.gov\/covid\/signs-symptoms\/index.html)\n- [People with Certain Medical Conditions and COVID-19](https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html)\n- [COVID-19 Vaccines](https:\/\/www.cdc.gov\/covid\/vaccines\/index.html)\n- [Testing](https:\/\/www.cdc.gov\/covid\/testing\/index.html)\n- [Treatment](https:\/\/www.cdc.gov\/covid\/treatment\/index.html)\n- [How to Protect Yourself and Others](https:\/\/www.cdc.gov\/covid\/prevention\/index.html)\n- [Tools and Resources](https:\/\/www.cdc.gov\/covid\/communication\/index.html)\n- [View all](https:\/\/www.cdc.gov\/covid\/site.html#gen)\n\n[Health Care Providers](https:\/\/www.cdc.gov\/covid\/hcp\/index.html)\n\n- [Interim Clinical Considerations](https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/index.html)\n- [Vaccine Product Information](https:\/\/www.cdc.gov\/covid\/hcp\/eui\/index.html)\n- [Clinical Care Quick Reference](https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/index.html)\n- [Infection Control Guidance](https:\/\/www.cdc.gov\/covid\/hcp\/infection-control\/index.html)\n- [Containing COVID-19 in Non-U.S. Healthcare Settings](https:\/\/www.cdc.gov\/covid\/hcp\/non-us-settings\/index.html)\n- [View all](https:\/\/www.cdc.gov\/covid\/site.html#hcp)\n\n[Public Health](https:\/\/www.cdc.gov\/covid\/php\/index.html)\n\n- [Surveillance and Data Analytics](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)\n- [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)\n- [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)\n- [CDC's Role in Tracking Variants](https:\/\/www.cdc.gov\/covid\/php\/variants\/index.html)\n- [SARS-CoV-2 Interagency Group](https:\/\/www.cdc.gov\/covid\/php\/interagency-group\/index.html)\n- [View all](https:\/\/www.cdc.gov\/covid\/site.html#php)\n\n[Home](https:\/\/www.cdc.gov\/covid\/index.html)\n\n[![Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/logo\/logo-notext.svg)](https:\/\/www.cdc.gov\/)\n\n[*search*](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)\n\n[Covid](https:\/\/www.cdc.gov\/covid\/index.html)\n\nMenu\n\nFor Everyone\n\n- [About COVID-19](https:\/\/www.cdc.gov\/covid\/about\/index.html)\n- [Symptoms](https:\/\/www.cdc.gov\/covid\/signs-symptoms\/index.html)\n- [People with Certain Medical Conditions and COVID-19](https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html)\n- [COVID-19 Vaccines](https:\/\/www.cdc.gov\/covid\/vaccines\/index.html)\n- [Testing](https:\/\/www.cdc.gov\/covid\/testing\/index.html)\n- [Treatment](https:\/\/www.cdc.gov\/covid\/treatment\/index.html)\n- [How to Protect Yourself and Others](https:\/\/www.cdc.gov\/covid\/prevention\/index.html)\n- [Tools and Resources](https:\/\/www.cdc.gov\/covid\/communication\/index.html)\n- [View All](https:\/\/www.cdc.gov\/covid\/site.html#gen)     [Home](https:\/\/www.cdc.gov\/covid\/index.html)\n\nHealth Care Providers\n\n- [Interim Clinical Considerations](https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/index.html)\n- [Vaccine Product Information](https:\/\/www.cdc.gov\/covid\/hcp\/eui\/index.html)\n- [Clinical Care Quick Reference](https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/index.html)\n- [Infection Control Guidance](https:\/\/www.cdc.gov\/covid\/hcp\/infection-control\/index.html)\n- [Containing COVID-19 in Non-U.S. Healthcare Settings](https:\/\/www.cdc.gov\/covid\/hcp\/non-us-settings\/index.html)\n- [View All](https:\/\/www.cdc.gov\/covid\/site.html#hcp)     [Home](https:\/\/www.cdc.gov\/covid\/hcp\/index.html)\n\nPublic Health\n\n- [Surveillance and Data Analytics](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)\n- [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)\n- [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)\n- [CDC's Role in Tracking Variants](https:\/\/www.cdc.gov\/covid\/php\/variants\/index.html)\n- [SARS-CoV-2 Interagency Group](https:\/\/www.cdc.gov\/covid\/php\/interagency-group\/index.html)\n- [View All](https:\/\/www.cdc.gov\/covid\/site.html#php)     [Home](https:\/\/www.cdc.gov\/covid\/php\/index.html)\n\n[Covid](https:\/\/www.cdc.gov\/covid\/index.html)\n\n[Surveillance and Data Analytics](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)   [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)   [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)   [CDC's Role in Tracking Variants](https:\/\/www.cdc.gov\/covid\/php\/variants\/index.html)   [SARS-CoV-2 Interagency Group](https:\/\/www.cdc.gov\/covid\/php\/interagency-group\/index.html)   [View Menu](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)\n\n![](data:image\/jpeg;base64,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)\n\n# Surveillance and Data Analytics\nMar. 19, 2026\n\nFor Public Health\n\n## Purpose\nThis page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page.\n\n## COVID-19 Surveillance Data in the United States\n### Early Indicators\nTest positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity.\n\n% Test Positivity\n\n## 2\\.1%\nWeek ending 2026-03-28   \nPrevious Week 2.3%\n\nSkip Over Chart Container\n\n0\n\n2\\.0%\n\n4\\.0%\n\n6\\.0%\n\n8\\.0%\n\n10\\.0%\n\n12\\.0%\n\n04\/12\/25\n\n06\/21\/25\n\n08\/30\/25\n\n11\/08\/25\n\n01\/17\/26\n\n03\/28\/26\n\n% ED visits diagnosed as COVID-19\n\n## 0\\.3%\nWeek ending 2026-03-28   \nPrevious Week 0.3%\n\nSkip Over Chart Container\n\n0\n\n0\\.5%\n\n1\\.0%\n\n1\\.5%\n\n04\/12\/25\n\n06\/21\/25\n\n08\/30\/25\n\n11\/08\/25\n\n01\/17\/26\n\n03\/28\/26\n### Severity Indicators\nHospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19.\n\nHospitalization rate per 100,000 population\n\n## 0\\.4\nWeek ending 2026-03-28   \nPrevious week 0.9\n\nSkip Over Chart Container\n\n0\n\n0\\.5\n\n1\\.0\n\n1\\.5\n\n2\\.0\n\n2\\.5\n\n04\/12\/25\n\n06\/21\/25\n\n08\/30\/25\n\n11\/08\/25\n\n01\/17\/26\n\n03\/28\/26\n\n% of All Deaths in U.S. Due to COVID-19\n\n## 0\\.3%\nWeek ending 2026-03-28   \nPrevious Week 0.3%\n\nSkip Over Chart Container\n\n0\n\n0\\.2%\n\n0\\.4%\n\n0\\.6%\n\n0\\.8%\n\n04\/12\/25\n\n06\/21\/25\n\n08\/30\/25\n\n11\/08\/25\n\n01\/17\/26\n\n03\/28\/26\n### COVID-19 Death Rates\n\n## Additional COVID-19 Data and Visualizations\n[Coronavirus Disease 2019 (COVID-19) Hospitalization Surveillance Network (COVID-NET)](https:\/\/www.cdc.gov\/covid\/php\/covid-net\/index.html)\n\nCOVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S.\n\n[COVIDVaxView](https:\/\/www.cdc.gov\/covidvaxview\/index.html)\n\nSurvey results at the national and state level monitoring COVID-19 vaccination uptake and confidence\n\n[COVID-19 Data from the National Center for Health Statistics](https:\/\/www.cdc.gov\/nchs\/covid19\/index.htm)\n\nNCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more\n\n[NWSS Wastewater Monitoring in the U.S.](https:\/\/www.cdc.gov\/nwss\/index.html)\n\nCDC shares wastewater data for infectious diseases to help make informed public health decisions.\n\n[Pediatric Acute Respiratory Illness (ARI) Interactive Dashboard](https:\/\/www.cdc.gov\/nvsn\/php\/ari-dashboard\/index.html)\n\nThe Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN.\n\n[The National Respiratory and Enteric Virus Surveillance System (NREVSS)](https:\/\/www.cdc.gov\/nrevss\/php\/dashboard\/index.html)\n\nNREVSS is a laboratory-based system that monitors respiratory and enteric virus activity.\n\n[Variants and Genomic Surveillance](https:\/\/www.cdc.gov\/covid\/php\/variants\/variants-and-genomic-surveillance.html)\n\nCDC uses genomic surveillance to identify and track SARS-CoV-2 variants.\n\n## On This Page\n- [COVID-19 Surveillance Data in the United States](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#cdc_survey_profile_purpose-covid-19-surveillance-data-in-the-united-states \"COVID-19 Surveillance Data in the United States\")\n- [Additional COVID-19 Data and Visualizations](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#cdc_survey_profile_surveys_used-additional-covid-19-data-and-visualizations \"Additional COVID-19 Data and Visualizations\")\n\n## Related Pages\n- [Preliminary Estimates of COVID-19 Burden](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden-estimates.html)\n- [How CDC Estimates the Burden of COVID-19 in the US](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/about-burden-estimates.html)\n- [Vaccine Effectiveness](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/vaccine-effectiveness.html)\n- [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)\n- [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)\n\n[View All Covid](https:\/\/www.cdc.gov\/covid\/site.html#php)\n\n[Preliminary Estimates of COVID-19 Burden](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden-estimates.html)\n\nMar. 19, 2026\n\n[Sources](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#content-sources) [Print](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#print) [Share](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#share)\n\n[Facebook](https:\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html \"Share to Facebook\")   [LinkedIn](https:\/\/www.linkedin.com\/shareArticle?url=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html&title=Surveillance%20and%20Data%20Analytics \"Share to LinkedIn\")   [Twitter](http:\/\/twitter.com\/share?url=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html&text=Surveillance%20and%20Data%20Analytics \"Share to Twitter\")   [Syndicate](https:\/\/tools.cdc.gov\/medialibrary\/index.aspx#\/sharecontent \"Embed this Page\")\n\nContent Source:\n\n[National Center for Immunization and Respiratory Diseases](https:\/\/www.cdc.gov\/ncird\/index.html); [Coronavirus and Other Respiratory Viruses Division](https:\/\/www.cdc.gov\/ncird\/divisions-offices\/index.html)\n\n## Related Pages\n- [Preliminary Estimates of COVID-19 Burden](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden-estimates.html)\n- [How CDC Estimates the Burden of COVID-19 in the US](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/about-burden-estimates.html)\n- [Vaccine Effectiveness](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/vaccine-effectiveness.html)\n- [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)\n- [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)\n\n[View All Covid](https:\/\/www.cdc.gov\/covid\/site.html#php)\n\nBack to Top\n\n## [Covid](https:\/\/www.cdc.gov\/covid\/index.html)\nCOVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2. It can be very contagious and spreads quickly.\n\n[View All](https:\/\/www.cdc.gov\/covid\/site.html)\n\n### [For Everyone](https:\/\/www.cdc.gov\/covid\/index.html#gen)\n- [About COVID-19](https:\/\/www.cdc.gov\/covid\/about\/index.html)\n- [Symptoms](https:\/\/www.cdc.gov\/covid\/signs-symptoms\/index.html)\n- [People with Certain Medical Conditions and COVID-19](https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html)\n- [COVID-19 Vaccines](https:\/\/www.cdc.gov\/covid\/vaccines\/index.html)\n- [Testing](https:\/\/www.cdc.gov\/covid\/testing\/index.html)\n- [Treatment](https:\/\/www.cdc.gov\/covid\/treatment\/index.html)\n- [How to Protect Yourself and Others](https:\/\/www.cdc.gov\/covid\/prevention\/index.html)\n- [Tools and Resources](https:\/\/www.cdc.gov\/covid\/communication\/index.html)\n\n### [Health Care Providers](https:\/\/www.cdc.gov\/covid\/hcp\/index.html#hcp)\n- [Interim Clinical Considerations](https:\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/index.html)\n- [Vaccine Product Information](https:\/\/www.cdc.gov\/covid\/hcp\/eui\/index.html)\n- [Clinical Care Quick Reference](https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/index.html)\n- [View All](https:\/\/www.cdc.gov\/covid\/site.html#hcp)\n\n### [Public Health](https:\/\/www.cdc.gov\/covid\/php\/index.html#php)\n- [Surveillance and Data Analytics](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html)\n- [SARS-CoV-2 Laboratory Biosafety Guidelines](https:\/\/www.cdc.gov\/covid\/php\/lab\/index.html)\n- [Antibody Seroprevalence](https:\/\/www.cdc.gov\/covid\/php\/antibody-seroprevalence\/index.html)\n- [View All](https:\/\/www.cdc.gov\/covid\/site.html#php)\n\n[Sign up for Email Updates](https:\/\/tools.cdc.gov\/campaignproxyservice\/subscriptions.aspx#featured)\n\n[Contact Us](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#contactUs)\n\n[Contact Us](https:\/\/www.cdc.gov\/cdc-info\/index.html)\n\n- [Call 800-232-4636](tel:800-232-4636)\n- [Contact CDC](https:\/\/www.cdc.gov\/cdc-info\/index.html)\n\n[About CDC](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#aboutCDC)\n\n[About CDC](https:\/\/www.cdc.gov\/about\/)\n\n- [Pressroom](https:\/\/www.cdc.gov\/media\/)\n- [Organization](https:\/\/www.cdc.gov\/about\/organization\/)\n- [Budget & Funding](https:\/\/www.cdc.gov\/budget\/)\n- [Careers & Jobs](https:\/\/jobs.cdc.gov\/index.html)\n\n[Policies](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#policies)\n\n- [Accessibility](https:\/\/www.cdc.gov\/other\/accessibility.html)\n- [External Links](https:\/\/www.cdc.gov\/Other\/disclaimer.html#exit-notification)\n- [Privacy](https:\/\/www.cdc.gov\/other\/privacy.html)\n- [Web Policies](https:\/\/www.cdc.gov\/Other\/policies.html)\n\n- [FOIA](https:\/\/www.cdc.gov\/foia\/)\n- [OIG](https:\/\/oig.hhs.gov\/)\n- [No Fear Act](https:\/\/www.cdc.gov\/oeeowe\/no-fear-act\/)\n- [Nondiscrimination](https:\/\/www.cdc.gov\/other\/nondiscrimination.html)\n- [Vulnerability Disclosure Policy](https:\/\/www.hhs.gov\/vulnerability-disclosure-policy\/index.html)\n\n[Languages](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#languages)\n\n[Languages](https:\/\/www.cdc.gov\/other\/other-languages\/index.html)\n\n- [Español](https:\/\/www.cdc.gov\/spanish\/)\n\n[Language Assistance](https:\/\/www.cdc.gov\/other\/language-assistance.html)\n\n- [Español](https:\/\/www.cdc.gov\/other\/language-assistance.html#Spanish)\n- [繁體中文](https:\/\/www.cdc.gov\/other\/language-assistance.html#Chinese)\n- [Tiếng Việt](https:\/\/www.cdc.gov\/other\/language-assistance.html#Vietnamese)\n- [한국어](https:\/\/www.cdc.gov\/other\/language-assistance.html#Korean)\n\n- [Tagalog](https:\/\/www.cdc.gov\/other\/language-assistance.html#Tagalog)\n- [Русский](https:\/\/www.cdc.gov\/other\/language-assistance.html#Russian)\n- [العربية](https:\/\/www.cdc.gov\/other\/language-assistance.html#Arabic)\n- [Kreyòl Ayisyen](https:\/\/www.cdc.gov\/other\/language-assistance.html#Haitian)\n\n- [Français](https:\/\/www.cdc.gov\/other\/language-assistance.html#French)\n- [Polski](https:\/\/www.cdc.gov\/other\/language-assistance.html#Polish)\n- [Português](https:\/\/www.cdc.gov\/other\/language-assistance.html#Portuguese)\n- [Italiano](https:\/\/www.cdc.gov\/other\/language-assistance.html#Italian)\n\n- [Deutsch](https:\/\/www.cdc.gov\/other\/language-assistance.html#German)\n- [日本語](https:\/\/www.cdc.gov\/other\/language-assistance.html#Japanese)\n- [فارسی](https:\/\/www.cdc.gov\/other\/language-assistance.html#Farsi)\n- [English](https:\/\/www.cdc.gov\/other\/language-assistance.html#English)\n\n[Archive](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#archive)\n\n- [CDC Archive](https:\/\/archive.cdc.gov\/)\n- [Public Health Publications](https:\/\/stacks.cdc.gov\/)\n\n[Contact Us](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#mobile-footer-contactUs)\n\n[Contact Us](https:\/\/www.cdc.gov\/cdc-info\/index.html)\n\n- [Call 800-232-4636](tel:800-232-4636)\n- [Contact CDC](https:\/\/www.cdc.gov\/cdc-info\/index.html)\n\n[About CDC](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#mobile-footer-aboutCDC)\n\n- [Pressroom](https:\/\/www.cdc.gov\/media\/)\n- [Organization](https:\/\/www.cdc.gov\/about\/organization\/)\n- [Budget & Funding](https:\/\/www.cdc.gov\/budget\/)\n- [Careers & Jobs](https:\/\/jobs.cdc.gov\/index.html)\n- [About CDC](https:\/\/www.cdc.gov\/about\/)\n\n[Policies](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#mobile-footer-policies)\n\n- [Accessibility](https:\/\/www.cdc.gov\/other\/accessibility.html)\n- [External Links](https:\/\/www.cdc.gov\/Other\/disclaimer.html#exit-notification)\n- [Privacy](https:\/\/www.cdc.gov\/other\/privacy.html)\n- [Web Policies](https:\/\/www.cdc.gov\/Other\/policies.html)\n\n- [FOIA](https:\/\/www.cdc.gov\/foia\/)\n- [OIG](https:\/\/oig.hhs.gov\/)\n- [No Fear Act](https:\/\/www.cdc.gov\/oeeowe\/no-fear-act\/)\n- [Nondiscrimination](https:\/\/www.cdc.gov\/other\/nondiscrimination.html)\n- [Vulnerability Disclosure Policy](https:\/\/www.hhs.gov\/vulnerability-disclosure-policy\/index.html)\n\n[Languages](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#mobile-footer-languages)\n\nLanguages\n\n- [Español](https:\/\/www.cdc.gov\/spanish\/)\n\nLanguage Assistance\n\n- [Español](https:\/\/www.cdc.gov\/other\/language-assistance.html#Spanish)\n- [繁體中文](https:\/\/www.cdc.gov\/other\/language-assistance.html#Chinese)\n- [Tiếng Việt](https:\/\/www.cdc.gov\/other\/language-assistance.html#Vietnamese)\n- [한국어](https:\/\/www.cdc.gov\/other\/language-assistance.html#Korean)\n- [Tagalog](https:\/\/www.cdc.gov\/other\/language-assistance.html#Tagalog)\n- [Русский](https:\/\/www.cdc.gov\/other\/language-assistance.html#Russian)\n- [العربية](https:\/\/www.cdc.gov\/other\/language-assistance.html#Arabic)\n- [Kreyòl Ayisyen](https:\/\/www.cdc.gov\/other\/language-assistance.html#Haitian)\n- [Français](https:\/\/www.cdc.gov\/other\/language-assistance.html#French)\n- [Polski](https:\/\/www.cdc.gov\/other\/language-assistance.html#Polish)\n- [Português](https:\/\/www.cdc.gov\/other\/language-assistance.html#Portuguese)\n- [Italiano](https:\/\/www.cdc.gov\/other\/language-assistance.html#Italian)\n- [Deutsch](https:\/\/www.cdc.gov\/other\/language-assistance.html#German)\n- [日本語](https:\/\/www.cdc.gov\/other\/language-assistance.html#Japanese)\n- [فارسی](https:\/\/www.cdc.gov\/other\/language-assistance.html#Farsi)\n- [English](https:\/\/www.cdc.gov\/other\/language-assistance.html#English)\n\n[Archive](https:\/\/www.cdc.gov\/covid\/php\/surveillance\/index.html#mobile-footer-archive)\n\n- [CDC Archive](https:\/\/archive.cdc.gov\/)\n- [Public Health Publications](https:\/\/stacks.cdc.gov\/)\n\n[![Centers for Disease Control and Prevention](https:\/\/www.cdc.gov\/TemplatePackage\/5.0\/img\/logo\/cdc-logo-tag-right.svg)](https:\/\/www.cdc.gov\/)\n\n[HHS.gov](https:\/\/hhs.gov\/) [USA.gov](https:\/\/usa.gov\/)\n\n0\\.8%","attrs_readable_markdown":"This page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page.\n\n## COVID-19 Surveillance Data in the United States\n### Early Indicators\nTest positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity.\n\n% Test Positivity\n\n## 2\\.1%\nWeek ending 2026-03-28   \nPrevious Week 2.3%\n\n% ED visits diagnosed as COVID-19\n\n## 0\\.3%\nWeek ending 2026-03-28   \nPrevious Week 0.3%\n### Severity Indicators\nHospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19.\n\nHospitalization rate per 100,000 population\n\n## 0\\.4\nWeek ending 2026-03-28   \nPrevious week 0.9\n\n% of All Deaths in U.S. Due to COVID-19\n\n## 0\\.3%\nWeek ending 2026-03-28   \nPrevious Week 0.3%\n### COVID-19 Death Rates\n\n## Additional COVID-19 Data and Visualizations\nCOVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S.\n\nSurvey results at the national and state level monitoring COVID-19 vaccination uptake and confidence\n\nNCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more\n\nCDC shares wastewater data for infectious diseases to help make informed public health decisions.\n\nThe Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN.\n\nNREVSS is a laboratory-based system that monitors respiratory and enteric virus activity.\n\nCDC uses genomic surveillance to identify and track SARS-CoV-2 variants.\n\nMar. 19, 2026","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

1 day ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.cdc.gov/covid/php/surveillance/index.html
Last Crawled	2026-04-06 08:26:41 (1 day ago)
First Indexed	2024-08-01 17:37:09 (1 year ago)
HTTP Status Code	200
Meta Title	Surveillance and Data Analytics \| Covid \| CDC
Meta Description	COVID-19 surveillance and data analytics
Meta Canonical	null
Boilerpipe Text	This page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page. COVID-19 Surveillance Data in the United States Early Indicators Test positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity. % Test Positivity 2.1% Week ending 2026-03-28 Previous Week 2.3% % ED visits diagnosed as COVID-19 0.3% Week ending 2026-03-28 Previous Week 0.3% Severity Indicators Hospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19. Hospitalization rate per 100,000 population 0.4 Week ending 2026-03-28 Previous week 0.9 % of All Deaths in U.S. Due to COVID-19 0.3% Week ending 2026-03-28 Previous Week 0.3% COVID-19 Death Rates Additional COVID-19 Data and Visualizations COVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S. Survey results at the national and state level monitoring COVID-19 vaccination uptake and confidence NCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more CDC shares wastewater data for infectious diseases to help make informed public health decisions. The Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN. NREVSS is a laboratory-based system that monitors respiratory and enteric virus activity. CDC uses genomic surveillance to identify and track SARS-CoV-2 variants. Mar. 19, 2026
Markdown	[Skip directly to site content](https://www.cdc.gov/covid/php/surveillance/index.html#content) [Skip directly to search](https://www.cdc.gov/covid/php/surveillance/index.html#cdc-search__input) [Skip directly to On This Page](https://www.cdc.gov/covid/php/surveillance/index.html#first-on-this-page) ![](https://www.cdc.gov/TemplatePackage/5.0/img/uswds/us_flag_small.png) An official website of the United States government [Here's how you know](https://www.cdc.gov/covid/php/surveillance/index.html#gov-notice) ![](https://www.cdc.gov/TemplatePackage/5.0/img/uswds/icon-dot-gov.svg) Official websites use .gov A .gov website belongs to an official government organization in the United States. ![](https://www.cdc.gov/TemplatePackage/5.0/img/uswds/icon-https.svg) Secure .gov websites use HTTPS A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. [![Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People](https://www.cdc.gov/TemplatePackage/5.0/img/logo/logo-notext.svg)](https://www.cdc.gov/) [Covid](https://www.cdc.gov/covid/index.html) Explore This Topic [For Everyone](https://www.cdc.gov/covid/index.html) - [About COVID-19](https://www.cdc.gov/covid/about/index.html) - [Symptoms](https://www.cdc.gov/covid/signs-symptoms/index.html) - [People with Certain Medical Conditions and COVID-19](https://www.cdc.gov/covid/risk-factors/index.html) - [COVID-19 Vaccines](https://www.cdc.gov/covid/vaccines/index.html) - [Testing](https://www.cdc.gov/covid/testing/index.html) - [Treatment](https://www.cdc.gov/covid/treatment/index.html) - [How to Protect Yourself and Others](https://www.cdc.gov/covid/prevention/index.html) - [Tools and Resources](https://www.cdc.gov/covid/communication/index.html) - [View all](https://www.cdc.gov/covid/site.html#gen) [Health Care Providers](https://www.cdc.gov/covid/hcp/index.html) - [Interim Clinical Considerations](https://www.cdc.gov/covid/hcp/vaccine-considerations/index.html) - [Vaccine Product Information](https://www.cdc.gov/covid/hcp/eui/index.html) - [Clinical Care Quick Reference](https://www.cdc.gov/covid/hcp/clinical-care/index.html) - [Infection Control Guidance](https://www.cdc.gov/covid/hcp/infection-control/index.html) - [Containing COVID-19 in Non-U.S. Healthcare Settings](https://www.cdc.gov/covid/hcp/non-us-settings/index.html) - [View all](https://www.cdc.gov/covid/site.html#hcp) [Public Health](https://www.cdc.gov/covid/php/index.html) - [Surveillance and Data Analytics](https://www.cdc.gov/covid/php/surveillance/index.html) - [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) - [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) - [CDC's Role in Tracking Variants](https://www.cdc.gov/covid/php/variants/index.html) - [SARS-CoV-2 Interagency Group](https://www.cdc.gov/covid/php/interagency-group/index.html) - [View all](https://www.cdc.gov/covid/site.html#php) [Home](https://www.cdc.gov/covid/index.html) [![Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People](https://www.cdc.gov/TemplatePackage/5.0/img/logo/logo-notext.svg)](https://www.cdc.gov/) [search](https://www.cdc.gov/covid/php/surveillance/index.html) [Covid](https://www.cdc.gov/covid/index.html) Menu For Everyone - [About COVID-19](https://www.cdc.gov/covid/about/index.html) - [Symptoms](https://www.cdc.gov/covid/signs-symptoms/index.html) - [People with Certain Medical Conditions and COVID-19](https://www.cdc.gov/covid/risk-factors/index.html) - [COVID-19 Vaccines](https://www.cdc.gov/covid/vaccines/index.html) - [Testing](https://www.cdc.gov/covid/testing/index.html) - [Treatment](https://www.cdc.gov/covid/treatment/index.html) - [How to Protect Yourself and Others](https://www.cdc.gov/covid/prevention/index.html) - [Tools and Resources](https://www.cdc.gov/covid/communication/index.html) - [View All](https://www.cdc.gov/covid/site.html#gen) [Home](https://www.cdc.gov/covid/index.html) Health Care Providers - [Interim Clinical Considerations](https://www.cdc.gov/covid/hcp/vaccine-considerations/index.html) - [Vaccine Product Information](https://www.cdc.gov/covid/hcp/eui/index.html) - [Clinical Care Quick Reference](https://www.cdc.gov/covid/hcp/clinical-care/index.html) - [Infection Control Guidance](https://www.cdc.gov/covid/hcp/infection-control/index.html) - [Containing COVID-19 in Non-U.S. Healthcare Settings](https://www.cdc.gov/covid/hcp/non-us-settings/index.html) - [View All](https://www.cdc.gov/covid/site.html#hcp) [Home](https://www.cdc.gov/covid/hcp/index.html) Public Health - [Surveillance and Data Analytics](https://www.cdc.gov/covid/php/surveillance/index.html) - [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) - [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) - [CDC's Role in Tracking Variants](https://www.cdc.gov/covid/php/variants/index.html) - [SARS-CoV-2 Interagency Group](https://www.cdc.gov/covid/php/interagency-group/index.html) - [View All](https://www.cdc.gov/covid/site.html#php) [Home](https://www.cdc.gov/covid/php/index.html) [Covid](https://www.cdc.gov/covid/index.html) [Surveillance and Data Analytics](https://www.cdc.gov/covid/php/surveillance/index.html) [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) [CDC's Role in Tracking Variants](https://www.cdc.gov/covid/php/variants/index.html) [SARS-CoV-2 Interagency Group](https://www.cdc.gov/covid/php/interagency-group/index.html) [View Menu](https://www.cdc.gov/covid/php/surveillance/index.html) ![](data:image/jpeg;base64,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) # Surveillance and Data Analytics Mar. 19, 2026 For Public Health ## Purpose This page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page. ## COVID-19 Surveillance Data in the United States ### Early Indicators Test positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity. % Test Positivity ## 2\.1% Week ending 2026-03-28 Previous Week 2.3% Skip Over Chart Container 0 2\.0% 4\.0% 6\.0% 8\.0% 10\.0% 12\.0% 04/12/25 06/21/25 08/30/25 11/08/25 01/17/26 03/28/26 % ED visits diagnosed as COVID-19 ## 0\.3% Week ending 2026-03-28 Previous Week 0.3% Skip Over Chart Container 0 0\.5% 1\.0% 1\.5% 04/12/25 06/21/25 08/30/25 11/08/25 01/17/26 03/28/26 ### Severity Indicators Hospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19. Hospitalization rate per 100,000 population ## 0\.4 Week ending 2026-03-28 Previous week 0.9 Skip Over Chart Container 0 0\.5 1\.0 1\.5 2\.0 2\.5 04/12/25 06/21/25 08/30/25 11/08/25 01/17/26 03/28/26 % of All Deaths in U.S. Due to COVID-19 ## 0\.3% Week ending 2026-03-28 Previous Week 0.3% Skip Over Chart Container 0 0\.2% 0\.4% 0\.6% 0\.8% 04/12/25 06/21/25 08/30/25 11/08/25 01/17/26 03/28/26 ### COVID-19 Death Rates ## Additional COVID-19 Data and Visualizations [Coronavirus Disease 2019 (COVID-19) Hospitalization Surveillance Network (COVID-NET)](https://www.cdc.gov/covid/php/covid-net/index.html) COVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S. [COVIDVaxView](https://www.cdc.gov/covidvaxview/index.html) Survey results at the national and state level monitoring COVID-19 vaccination uptake and confidence [COVID-19 Data from the National Center for Health Statistics](https://www.cdc.gov/nchs/covid19/index.htm) NCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more [NWSS Wastewater Monitoring in the U.S.](https://www.cdc.gov/nwss/index.html) CDC shares wastewater data for infectious diseases to help make informed public health decisions. [Pediatric Acute Respiratory Illness (ARI) Interactive Dashboard](https://www.cdc.gov/nvsn/php/ari-dashboard/index.html) The Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN. [The National Respiratory and Enteric Virus Surveillance System (NREVSS)](https://www.cdc.gov/nrevss/php/dashboard/index.html) NREVSS is a laboratory-based system that monitors respiratory and enteric virus activity. [Variants and Genomic Surveillance](https://www.cdc.gov/covid/php/variants/variants-and-genomic-surveillance.html) CDC uses genomic surveillance to identify and track SARS-CoV-2 variants. ## On This Page - [COVID-19 Surveillance Data in the United States](https://www.cdc.gov/covid/php/surveillance/index.html#cdc_survey_profile_purpose-covid-19-surveillance-data-in-the-united-states "COVID-19 Surveillance Data in the United States") - [Additional COVID-19 Data and Visualizations](https://www.cdc.gov/covid/php/surveillance/index.html#cdc_survey_profile_surveys_used-additional-covid-19-data-and-visualizations "Additional COVID-19 Data and Visualizations") ## Related Pages - [Preliminary Estimates of COVID-19 Burden](https://www.cdc.gov/covid/php/surveillance/burden-estimates.html) - [How CDC Estimates the Burden of COVID-19 in the US](https://www.cdc.gov/covid/php/surveillance/about-burden-estimates.html) - [Vaccine Effectiveness](https://www.cdc.gov/covid/php/surveillance/vaccine-effectiveness.html) - [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) - [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) [View All Covid](https://www.cdc.gov/covid/site.html#php) [Preliminary Estimates of COVID-19 Burden](https://www.cdc.gov/covid/php/surveillance/burden-estimates.html) Mar. 19, 2026 [Sources](https://www.cdc.gov/covid/php/surveillance/index.html#content-sources) [Print](https://www.cdc.gov/covid/php/surveillance/index.html#print) [Share](https://www.cdc.gov/covid/php/surveillance/index.html#share) [Facebook](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html "Share to Facebook") [LinkedIn](https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html&title=Surveillance%20and%20Data%20Analytics "Share to LinkedIn") [Twitter](http://twitter.com/share?url=https%3A%2F%2Fwww.cdc.gov%2Fcovid%2Fphp%2Fsurveillance%2Findex.html&text=Surveillance%20and%20Data%20Analytics "Share to Twitter") [Syndicate](https://tools.cdc.gov/medialibrary/index.aspx#/sharecontent "Embed this Page") Content Source: [National Center for Immunization and Respiratory Diseases](https://www.cdc.gov/ncird/index.html); [Coronavirus and Other Respiratory Viruses Division](https://www.cdc.gov/ncird/divisions-offices/index.html) ## Related Pages - [Preliminary Estimates of COVID-19 Burden](https://www.cdc.gov/covid/php/surveillance/burden-estimates.html) - [How CDC Estimates the Burden of COVID-19 in the US](https://www.cdc.gov/covid/php/surveillance/about-burden-estimates.html) - [Vaccine Effectiveness](https://www.cdc.gov/covid/php/surveillance/vaccine-effectiveness.html) - [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) - [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) [View All Covid](https://www.cdc.gov/covid/site.html#php) Back to Top ## [Covid](https://www.cdc.gov/covid/index.html) COVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2. It can be very contagious and spreads quickly. [View All](https://www.cdc.gov/covid/site.html) ### [For Everyone](https://www.cdc.gov/covid/index.html#gen) - [About COVID-19](https://www.cdc.gov/covid/about/index.html) - [Symptoms](https://www.cdc.gov/covid/signs-symptoms/index.html) - [People with Certain Medical Conditions and COVID-19](https://www.cdc.gov/covid/risk-factors/index.html) - [COVID-19 Vaccines](https://www.cdc.gov/covid/vaccines/index.html) - [Testing](https://www.cdc.gov/covid/testing/index.html) - [Treatment](https://www.cdc.gov/covid/treatment/index.html) - [How to Protect Yourself and Others](https://www.cdc.gov/covid/prevention/index.html) - [Tools and Resources](https://www.cdc.gov/covid/communication/index.html) ### [Health Care Providers](https://www.cdc.gov/covid/hcp/index.html#hcp) - [Interim Clinical Considerations](https://www.cdc.gov/covid/hcp/vaccine-considerations/index.html) - [Vaccine Product Information](https://www.cdc.gov/covid/hcp/eui/index.html) - [Clinical Care Quick Reference](https://www.cdc.gov/covid/hcp/clinical-care/index.html) - [View All](https://www.cdc.gov/covid/site.html#hcp) ### [Public Health](https://www.cdc.gov/covid/php/index.html#php) - [Surveillance and Data Analytics](https://www.cdc.gov/covid/php/surveillance/index.html) - [SARS-CoV-2 Laboratory Biosafety Guidelines](https://www.cdc.gov/covid/php/lab/index.html) - [Antibody Seroprevalence](https://www.cdc.gov/covid/php/antibody-seroprevalence/index.html) - [View All](https://www.cdc.gov/covid/site.html#php) [Sign up for Email Updates](https://tools.cdc.gov/campaignproxyservice/subscriptions.aspx#featured) [Contact Us](https://www.cdc.gov/covid/php/surveillance/index.html#contactUs) [Contact Us](https://www.cdc.gov/cdc-info/index.html) - [Call 800-232-4636](tel:800-232-4636) - [Contact CDC](https://www.cdc.gov/cdc-info/index.html) [About CDC](https://www.cdc.gov/covid/php/surveillance/index.html#aboutCDC) [About CDC](https://www.cdc.gov/about/) - [Pressroom](https://www.cdc.gov/media/) - [Organization](https://www.cdc.gov/about/organization/) - [Budget & Funding](https://www.cdc.gov/budget/) - [Careers & Jobs](https://jobs.cdc.gov/index.html) [Policies](https://www.cdc.gov/covid/php/surveillance/index.html#policies) - [Accessibility](https://www.cdc.gov/other/accessibility.html) - [External Links](https://www.cdc.gov/Other/disclaimer.html#exit-notification) - [Privacy](https://www.cdc.gov/other/privacy.html) - [Web Policies](https://www.cdc.gov/Other/policies.html) - [FOIA](https://www.cdc.gov/foia/) - [OIG](https://oig.hhs.gov/) - [No Fear Act](https://www.cdc.gov/oeeowe/no-fear-act/) - [Nondiscrimination](https://www.cdc.gov/other/nondiscrimination.html) - [Vulnerability Disclosure Policy](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Languages](https://www.cdc.gov/covid/php/surveillance/index.html#languages) [Languages](https://www.cdc.gov/other/other-languages/index.html) - [Español](https://www.cdc.gov/spanish/) [Language Assistance](https://www.cdc.gov/other/language-assistance.html) - [Español](https://www.cdc.gov/other/language-assistance.html#Spanish) - [繁體中文](https://www.cdc.gov/other/language-assistance.html#Chinese) - [Tiếng Việt](https://www.cdc.gov/other/language-assistance.html#Vietnamese) - [한국어](https://www.cdc.gov/other/language-assistance.html#Korean) - [Tagalog](https://www.cdc.gov/other/language-assistance.html#Tagalog) - [Русский](https://www.cdc.gov/other/language-assistance.html#Russian) - [العربية](https://www.cdc.gov/other/language-assistance.html#Arabic) - [Kreyòl Ayisyen](https://www.cdc.gov/other/language-assistance.html#Haitian) - [Français](https://www.cdc.gov/other/language-assistance.html#French) - [Polski](https://www.cdc.gov/other/language-assistance.html#Polish) - [Português](https://www.cdc.gov/other/language-assistance.html#Portuguese) - [Italiano](https://www.cdc.gov/other/language-assistance.html#Italian) - [Deutsch](https://www.cdc.gov/other/language-assistance.html#German) - [日本語](https://www.cdc.gov/other/language-assistance.html#Japanese) - [فارسی](https://www.cdc.gov/other/language-assistance.html#Farsi) - [English](https://www.cdc.gov/other/language-assistance.html#English) [Archive](https://www.cdc.gov/covid/php/surveillance/index.html#archive) - [CDC Archive](https://archive.cdc.gov/) - [Public Health Publications](https://stacks.cdc.gov/) [Contact Us](https://www.cdc.gov/covid/php/surveillance/index.html#mobile-footer-contactUs) [Contact Us](https://www.cdc.gov/cdc-info/index.html) - [Call 800-232-4636](tel:800-232-4636) - [Contact CDC](https://www.cdc.gov/cdc-info/index.html) [About CDC](https://www.cdc.gov/covid/php/surveillance/index.html#mobile-footer-aboutCDC) - [Pressroom](https://www.cdc.gov/media/) - [Organization](https://www.cdc.gov/about/organization/) - [Budget & Funding](https://www.cdc.gov/budget/) - [Careers & Jobs](https://jobs.cdc.gov/index.html) - [About CDC](https://www.cdc.gov/about/) [Policies](https://www.cdc.gov/covid/php/surveillance/index.html#mobile-footer-policies) - [Accessibility](https://www.cdc.gov/other/accessibility.html) - [External Links](https://www.cdc.gov/Other/disclaimer.html#exit-notification) - [Privacy](https://www.cdc.gov/other/privacy.html) - [Web Policies](https://www.cdc.gov/Other/policies.html) - [FOIA](https://www.cdc.gov/foia/) - [OIG](https://oig.hhs.gov/) - [No Fear Act](https://www.cdc.gov/oeeowe/no-fear-act/) - [Nondiscrimination](https://www.cdc.gov/other/nondiscrimination.html) - [Vulnerability Disclosure Policy](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Languages](https://www.cdc.gov/covid/php/surveillance/index.html#mobile-footer-languages) Languages - [Español](https://www.cdc.gov/spanish/) Language Assistance - [Español](https://www.cdc.gov/other/language-assistance.html#Spanish) - [繁體中文](https://www.cdc.gov/other/language-assistance.html#Chinese) - [Tiếng Việt](https://www.cdc.gov/other/language-assistance.html#Vietnamese) - [한국어](https://www.cdc.gov/other/language-assistance.html#Korean) - [Tagalog](https://www.cdc.gov/other/language-assistance.html#Tagalog) - [Русский](https://www.cdc.gov/other/language-assistance.html#Russian) - [العربية](https://www.cdc.gov/other/language-assistance.html#Arabic) - [Kreyòl Ayisyen](https://www.cdc.gov/other/language-assistance.html#Haitian) - [Français](https://www.cdc.gov/other/language-assistance.html#French) - [Polski](https://www.cdc.gov/other/language-assistance.html#Polish) - [Português](https://www.cdc.gov/other/language-assistance.html#Portuguese) - [Italiano](https://www.cdc.gov/other/language-assistance.html#Italian) - [Deutsch](https://www.cdc.gov/other/language-assistance.html#German) - [日本語](https://www.cdc.gov/other/language-assistance.html#Japanese) - [فارسی](https://www.cdc.gov/other/language-assistance.html#Farsi) - [English](https://www.cdc.gov/other/language-assistance.html#English) [Archive](https://www.cdc.gov/covid/php/surveillance/index.html#mobile-footer-archive) - [CDC Archive](https://archive.cdc.gov/) - [Public Health Publications](https://stacks.cdc.gov/) [![Centers for Disease Control and Prevention](https://www.cdc.gov/TemplatePackage/5.0/img/logo/cdc-logo-tag-right.svg)](https://www.cdc.gov/) [HHS.gov](https://hhs.gov/) [USA.gov](https://usa.gov/) 0\.8%
Readable Markdown	This page provides an overview of COVID-19 data and trends over time. Other COVID-19 related data visualizations (previously on CDC’s COVID Data Tracker) are provided in the resources section at the bottom of this page. ## COVID-19 Surveillance Data in the United States ### Early Indicators Test positivity (the percentage of total reported tests that are positive) and the percentage of total emergency department visits due to COVID-19 are key metrics to assess the impact of COVID-19 on communities. For public health professionals, these metrics act as early indicators of potential increases in COVID-19 activity. % Test Positivity ## 2\.1% Week ending 2026-03-28 Previous Week 2.3% % ED visits diagnosed as COVID-19 ## 0\.3% Week ending 2026-03-28 Previous Week 0.3% ### Severity Indicators Hospitalizations and deaths are key metrics for assessing the severity and disease burden of COVID-19, including which groups are at the increased risk of severe COVID-19. Hospitalization rate per 100,000 population ## 0\.4 Week ending 2026-03-28 Previous week 0.9 % of All Deaths in U.S. Due to COVID-19 ## 0\.3% Week ending 2026-03-28 Previous Week 0.3% ### COVID-19 Death Rates ## Additional COVID-19 Data and Visualizations COVID-NET monitors COVID-19-associated hospitalizations among children and adults in the U.S. Survey results at the national and state level monitoring COVID-19 vaccination uptake and confidence NCHS provides timely data on deaths, mental health, access to health care, telemedicine, and more CDC shares wastewater data for infectious diseases to help make informed public health decisions. The Pediatric Acute Respiratory Illness dashboard shows respiratory virus data from CDC's NVSN. NREVSS is a laboratory-based system that monitors respiratory and enteric virus activity. CDC uses genomic surveillance to identify and track SARS-CoV-2 variants. Mar. 19, 2026
Shard	5 (laksa)
Root Hash	17308952984333333205
Unparsed URL	gov,cdc!www,/covid/php/surveillance/index.html s443